As part of turnaround, Solid Bio reports promising initial data for Duchenne gene therapy
Solid Biosciences reported that three children with Duchenne muscular dystrophy who received its gene therapy saw high levels of a key muscle protein called microdystrophin …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
